Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565) |
---|
03/03/2015 | US8969327 Substituted androst-4-ene diones |
01/27/2015 | US8940719 Lithocholic acid analogues that inhibit sialyltransferase |
01/08/2015 | US20150011739 Tandem facial amphiphiles |
01/01/2015 | US20150005518 Process for alkynylating 16-substituted-17-keto steroids |
10/30/2014 | US20140323748 Water-soluble ursodeoxycholic acid prodrugs |
09/23/2014 | US8841284 Compound having neurite-outgrowing activity |
09/02/2014 | US8822441 Ecdysterone synthesis derivative, preparation method and use thereof |
07/08/2014 | US8771629 Nano-carbon material production apparatus and method |
06/25/2014 | CN101568547B 作为17βHSD抑制剂的被取代的雌三烯衍生物 As 17βHSD inhibitors substituted derivatives of estratrienes |
06/19/2014 | WO2014091158A1 Testosterone derivatives with a carboxyalkyl substitution in position 3 and use thereof for the production of labelled steroids for determining the concentration of testosterone in a biological sample |
06/04/2014 | EP2736918A1 Progesterone antagonists |
06/04/2014 | CN103842370A Progesterone antagonists |
05/20/2014 | US8729257 Hybrid lipid compounds based on pentaerythritol, intermediates, preparation methods and use thereof |
04/17/2014 | US20140107089 Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
04/15/2014 | CA2642566C 17-phosphorous steroid derivatives useful as progesterone receptor modulators |
04/09/2014 | EP2714710A1 Process for the production of estetrol intermediates |
04/02/2014 | CN103703014A Process for the production of estetrol intermediates |
04/01/2014 | CA2669767C Progesterone receptor antagonists |
02/26/2014 | CN103601786A Preparation method of methylprednisolone key intermediate |
02/19/2014 | CN103588848A Synthetic method for ginsenoside M1 and tri-methyl-chlorosilane full etherification reaction |
12/27/2013 | WO2013192097A1 Preparation, uses and solid forms of obeticholic acid |
12/27/2013 | CA2877122A1 Preparation, uses and solid forms of obeticholic acid |
12/11/2013 | CN103435676A Phytosterol phosphorylation amino-acid ester derivative and synthetic method thereof |
11/13/2013 | CN102516348B 16S-Methyl-20S-droxypregna compound, and synthesis method and uses thereof |
10/29/2013 | US8569276 Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
10/03/2013 | WO2013034780A3 Process for the preparation of estetrol and related compounds |
08/21/2013 | CN103254266A Steroid zinc metal complex and preparation method thereof as well as application of complex in preparation of antitumor medicines |
07/24/2013 | EP2616477A2 6-substituted demethyl-estradiol derivatives as er-beta agonists |
07/03/2013 | CN103183715A Furostan saponin derivative and purpose thereof |
06/27/2013 | WO2013091120A1 Protected linker compounds |
05/22/2013 | EP2594577A1 Process for preparing guggulsterones and guggulsterol |
04/17/2013 | CN103044514A Preparation method of 3beta-hydroxy-6-thiosemicarbazone steroid metal complex and application of metal complex in antineoplastic drug |
04/03/2013 | CN102234303B Novel ecdysterone synthetic derivative and preparation method and application thereof |
03/20/2013 | CN102311478B Composite lipid comprising cholesterol group and application thereof |
03/13/2013 | EP2567966A1 Novel ecdysterone synthesis derivative, preparation method and use thereof |
02/28/2013 | US20130053586 Novel Ecdysterone Synthesis Derivative, Preparation Method and Use Thereof |
02/28/2013 | US20130053507 Hydrophobic ceragenin compounds and devices incorporating same |
02/28/2013 | US20130052131 Nanoparticles, methods of making nanoparticles, and methods of use |
02/13/2013 | EP2556083A2 Non-hormonal steroid modulators of nf- kappa b for treatment of disease |
01/31/2013 | WO2013016725A1 Progesterone antagonists |
01/31/2013 | CA2846573A1 Progesterone antagonists |
01/09/2013 | EP2543674A1 Method for producing silylenol ethers |
12/06/2012 | WO2012164096A1 Process for the production of estetrol intermediates |
12/06/2012 | CA2835981A1 Process for the production of estetrol intermediates |
11/28/2012 | CN102796155A Nucleotide and oligonucleotide prodrugs |
11/08/2012 | US20120283217 Modulators of amyloid-beta production |
10/30/2012 | CA2669355C Guggulphospholipid methods and compositions |
10/03/2012 | CN101541823B Progesterone receptor antagonists |
09/25/2012 | US8273727 Lipid-analogous phosphoric triesters |
09/19/2012 | CN101421290B 17-phosphorous steroid derivatives useful as progesterone receptor modulators |
09/12/2012 | EP2497776A2 Process for the production of tibolone |
09/05/2012 | CN101942006B Hydroxyl group/keto group synchronous derivatization method of endocrine disturbing chemicals in steroid environment |
09/05/2012 | CN101622268B Industrial method for the synthesis of 17-acetoxy-11beta-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process |
09/04/2012 | CA2500768C Lipid-analog phosphoric acid triester |
08/23/2012 | US20120215006 Synthesis of phosphoric esters |
08/02/2012 | US20120195988 Therapeutic Uses for Plants of the Capsicum Genus |
06/27/2012 | EP1989217B1 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
06/27/2012 | CN102516348A 16S-Methyl-20S-droxypregna compound, and synthesis method and uses thereof |
06/13/2012 | EP2463292A1 Compound having neurite-outgrowing activity |
05/15/2012 | CA2517893C Use as medications of cholest-4-en-3-one derivatives, pharmaceutical compounds containing them, new derivatives and their preparation process |
05/10/2012 | US20120116064 Hybrid lipid compounds based on pentaerythritol, intermediates, preparation methods and use thereof |
03/22/2012 | US20120071570 Novel acyl acidic amino acid ester |
03/14/2012 | EP2427472A1 Lipophilic polynucleotide conjugates |
02/07/2012 | CA2488535C Glucocorticoid receptor ligands for the treatment of metabolic disorders |
01/24/2012 | CA2163748C Methods and compositions for inducing sleep |
01/11/2012 | CN102311478A Composite lipid comprising cholesterol group and intermediate, preparation method as well as application thereof |
11/10/2011 | WO2011137759A1 Novel ecdysterone synthesis derivative, preparation method and use thereof |
11/09/2011 | CN102234303A Novel ecdysterone synthetic derivative and preparation method and application thereof |
10/12/2011 | EP2160398B1 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11ß-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS |
10/05/2011 | EP1706415B1 Lipid- derivatized bisphosphonic acid |
10/05/2011 | CN101415720B 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
09/14/2011 | EP2364085A1 Releasable cationic lipids for nucleic acids delivery systems |
09/06/2011 | US8013147 Heterocyclic compounds and their use in the detection of nucleic acids |
08/23/2011 | US8003629 21-substituted progesterone derivatives as new antiprogestational agents |
07/21/2011 | US20110177156 Sterol-Modified Amphiphilic Lipids |
07/07/2011 | WO2011081937A1 Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
07/07/2011 | US20110165603 Small molecule fluorescent sensors for detection of post-translationalmodifications and protein interactions in bioassays |
04/07/2011 | US20110082306 Birch reduction of steroid substrates via alkali metal - silica gel materials |
03/17/2011 | WO2010114305A3 Pegylated betulin derivative, and cosmetic composition containing the same |
03/16/2011 | EP2294077A1 Corticosteroid linked beta-agonist compounds for use in therapy |
03/09/2011 | EP2292588A1 Ceramide dimers and their use as medicine or cosmetic preparation |
02/24/2011 | US20110046402 Novel method and intermediates for preparing 19-norsteroid compounds |
02/16/2011 | EP2284176A1 Process for preparing guggulsterones and guggulsterol |
02/15/2011 | CA2628883C Novel 3'-modified oligonucleotide derivatives |
02/08/2011 | US7884222 Process for the production of tibolone |
01/12/2011 | CN101942006A Hydroxyl group/keto group synchronous derivatization method of steroid environment endocrine disturbing chemicals |
01/05/2011 | EP2268655A2 Birch reduction of steroid substrates via alkali metal-silica gel materials |
11/24/2010 | CN101896498A Method for the aromatization of 19-nor-androst-4-en-3-ones into estra-1,3,5(10)-trienes |
11/18/2010 | WO2010132743A1 Corticosteroid beta-agonist compounds for use in therapy |
11/16/2010 | CA2185123C Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses |
11/03/2010 | EP2246359A1 Process for obtaining fluorometholone and intermediates therefor |
10/28/2010 | WO2010122096A1 Process for obtaining fluorometholone and intermediates therefor |
10/20/2010 | EP1381357B1 Glycyrrhetinic acid derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
10/07/2010 | WO2010114305A2 Pegylated betulin derivative, and cosmetic composition containing the same |
09/29/2010 | EP2231692A1 Method for the aromatization of 19-nor-androst-4-en-3-ones into estra-1,3,5(10)-trienes |
09/23/2010 | US20100240916 Process for obtaining steroidal phosphate compounds |
08/25/2010 | EP2219587A1 Sterol-modified amphiphilic lipids |
08/12/2010 | US20100204497 Process For The Preparation of 7 alpha-Methylsteroids |
07/22/2010 | US20100183517 Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods Of Use |
07/20/2010 | US7759330 21-substituted progesterone derivatives as new antiprogestational agents |